Greg Zante's Net Worth
$25.6 Million
Who is Greg Zante?
Greg Zante has an estimated net worth of $25.6 Million. This is based on reported shares across multiple companies, which include SANGAMO BIOSCIENCES INC, and Viking Therapeutics, Inc..
SEC CIK
Greg Zante's CIK is 0001264949
Past Insider Trading and Trends
2023 was Greg Zante's most active year for acquiring shares with 15 total transactions. Greg Zante's most active month to acquire stocks was the month of December. 2023 was Greg Zante's most active year for disposing of shares, totalling 20 transactions. Greg Zante's most active month to dispose stocks was the month of December. 2023 saw Greg Zante paying a total of $1,566,490.00 for 581,334 shares, this is the most they've acquired in one year. In 2024 Greg Zante cashed out on 231,838 shares for a total of $10,385,787.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SANGAMO BIOSCIENCES INC (SGMO) Snapshot price: $0.72
VP, Finance & Administration
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.06 | -$789.00 |
0
|
Scheduled
|
Feb 14
| ||
Form 4
|
—
|
0
|
$8.49 | -$35,269.28 |
0
|
Scheduled
|
Feb 14
| ||
Form 4
|
—
|
0
|
$8.82 | -$40,449.86 |
0
|
Scheduled
|
Jan 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
—
|
0
|
$10.09 | -$57,108.03 |
0
|
Scheduled
|
Dec 7
| ||
Form 4
| -48.09% | -642.00 |
$10.90 | -$180,801.12 | 693 |
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| -100.00% | -827.00 |
$5.81 | -$102,674.99 |
0
|
Dec 11 - Dec 12
| |||
Form 4
|
—
|
0
|
$5.45 | -$39,200.00 |
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
$4.03 | -$11,102.80 |
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viking Therapeutics, Inc. (VKTX) Snapshot price: $54.4022
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.15% | -37.69K |
$42.05 | -$9,384,881.88 | 149.37K |
Oct 28
| |||
Form 4
| +6.98% | 12.2K |
$57.15 | -$922,212.06 | 187.05K |
Jul 29 - Jul 30
| |||
Form 4
| -15.68% | -32.51K |
$39.78 | -$4,819,722.65 | 174.85K |
Scheduled
|
May 3
| ||
Form 4
| +7.83% | 15.06K |
$83.34 | -$1,384,277.40 | 207.36K |
Mar 27
| |||
Form 4
| +6.40% | 11.57K |
$85.22 | -$1,712,325.46 | 192.3K |
Mar 1
| |||
Form 4
| +12.68% | 20.34K |
$17.71 | -$1,380,964.56 | 180.73K |
Jan 3 - Jan 4
| |||
Form 4
|
—
|
0
|
$16.54 | -$51,975.00 | 149.28K |
Apr 17
| |||
Form 4
|
—
|
0
|
$11.79 | -$1,216,506.26 | 149.28K |
Apr 11 - Apr 12
| |||
Form 4
| -19.33% | -35.78K |
$12.35 | -$2,829,824.22 | 149.28K |
Mar 30 - Apr 3
| |||
Form 4
| +33.62% | 46.56K |
$8.76 | -$563,422.32 | 185.06K |
Dec 30 - Jan 4
| |||
Form 4
| +43.62% | 41.4K |
$4.69 | -$55,931.06 | 136.3K |
Jan 3 - Jan 4
| |||
Form 4
| +4.84% | 4.36K |
$6.50 | -$14,989.00 | 94.48K |
Sep 28
| |||
Form 4
| -0.89% | -808.00 |
$6.68 | -$5,397.44 | 89.75K |
Jan 19
| |||
Form 4
| +313.59% | 68.66K |
$5.80 | -$16,164.60 | 90.56K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||